{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:09:22Z","timestamp":1794708562341,"version":"4.9.1"},"reference-count":59,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"unspecified","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2025,11,25]]},"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To characterise phenotype and functional profibrotic M2 markers in circulating monocytes and cultured monocyte-derived macrophages (MDMs) from systemic sclerosis (SSc) patients (pts) with progressive interstitial lung disease (ILD) (prog-ILD), non-progressive ILD (no-prog-ILD) and without ILD (no-ILD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Fifty-five SSc pts and 20 age-matched healthy controls were evaluated. In 36 SSc pts, circulating monocytes expressing toll-like receptor-4 (TLR4, M1 marker) and M2 phenotype markers (CD204, CD206, CD163) were detected by flow cytometry. Moreover, MDMs of 29 SSc pts were analysed by quantitative real-time PCR and Western blotting for gene expression and protein synthesis with regard to the production of profibrotic mediators: transforming growth factor-\u00df1 (TGF\u00df1), Mer tyrosine kinase receptor (MerTK) and arginase-1 (ARG1). Interleukin-6 and 4 (IL6, IL4), as well as C-C motif chemokine ligand 2 and 18 (CCL2\/MCP1 and CCL18) from culture medium, were evaluated by enzyme-linked immunosorbent assay (ELISA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Prog-ILD SSc pts showed a higher percentage of TLR4\n                      <jats:sup>+<\/jats:sup>\n                      CD204\n                      <jats:sup>+<\/jats:sup>\n                      CD206\n                      <jats:sup>+<\/jats:sup>\n                      CD163\n                      <jats:sup>+<\/jats:sup>\n                      monocytes versus no-prog-ILD, and significantly higher compared with no-ILD SSc pts.\n                    <\/jats:p>\n                    <jats:p>Interestingly, MDMs from prog-ILD SSc pts showed a significantly higher gene expression and protein synthesis of TGF\u03b21, and a significantly higher protein synthesis of MerTK, CD206, IL4 and CCL18 compared with no-prog-ILD SSc pts. Finally, gene expression and protein synthesis of TGF\u03b21, TLR4, CD206, CD163, ARG1, MerTK and IL6 were significantly increased in prog-ILD SSc versus no-ILD SSc MDMs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Cultured MDMs from circulating monocytes in SSc pts with prog-ILD show markedly increased profibrotic biomarkers and mediator expression, indicating an enhanced fibrotic phenotype compared to non-prog and no-ILD SSc pts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/rmdopen-2025-006135","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T11:45:24Z","timestamp":1765453524000},"page":"e006135","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Circulating monocytes from systemic sclerosis patients with progressive interstitial lung disease preferentially express M2 phenotype markers: in vitro and ex vivo study"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6271-7945","authenticated-orcid":false,"given":"Vanessa","family":"Smith","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Internal Medicine, University Hospital Ghent, Ghent, Flanders, Belgium"},{"name":"Unit for Molecular Immunology and Infammation, Flemish Institute for Technological Research, Mol, Flanders, Belgium"},{"name":"Department of Internal Medicine, Ghent University Hospital, University of Ghent, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Soldano","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Medical Specialities (Di.M.I.), University of Genoa, Genoa, Liguria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Campitiello","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Medical Specialities (Di.M.I.), University of Genoa, Genoa, Liguria, Italy"},{"name":"Department of Experimental Medicine (DIMES), University of Genoa, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Montagna","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Medical Specialities (Di.M.I.), University of Genoa, Genoa, Liguria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cere","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Medical Specialities (Di.M.I.), University of Genoa, Genoa, Liguria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvis","family":"Hysa","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Medical Specialities (Di.M.I.), University of Genoa, Genoa, Liguria, Italy"},{"name":"Department of Experimental Medicine (DIMES), University of Genoa, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Vojinovic","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Medical Specialities (Di.M.I.), University of Genoa, Genoa, Liguria, Italy"},{"name":"IRCCS Ospedale Policlinico San Martino, Genoa, Liguria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Pizzorni","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Medical Specialities (Di.M.I.), University of Genoa, Genoa, Liguria, Italy"},{"name":"IRCCS Ospedale Policlinico San Martino, Genoa, Liguria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Paolino","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Medical Specialities (Di.M.I.), University of Genoa, Genoa, Liguria, Italy"},{"name":"IRCCS Ospedale Policlinico San Martino, Genoa, Liguria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Sulli","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Medical Specialities (Di.M.I.), University of Genoa, Genoa, Liguria, Italy"},{"name":"IRCCS Ospedale Policlinico San Martino, Genoa, Liguria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4732-0306","authenticated-orcid":false,"given":"Emanuele","family":"Gotelli","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Medical Specialities (Di.M.I.), University of Genoa, Genoa, Liguria, Italy"},{"name":"IRCCS Ospedale Policlinico San Martino, Genoa, Liguria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5396-0932","authenticated-orcid":false,"given":"Maurizio","family":"Cutolo","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Medical Specialities (Di.M.I.), University of Genoa, Genoa, Liguria, Italy"},{"name":"IRCCS Ospedale Policlinico San Martino, Genoa, Liguria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"2026050410252211000_11.4.e006135.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01692-0"},{"key":"2026050410252211000_11.4.e006135.2","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1614915"},{"key":"2026050410252211000_11.4.e006135.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00683-2"},{"key":"2026050410252211000_11.4.e006135.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30933-9"},{"key":"2026050410252211000_11.4.e006135.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0806188"},{"key":"2026050410252211000_11.4.e006135.6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.114264"},{"key":"2026050410252211000_11.4.e006135.7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211448"},{"key":"2026050410252211000_11.4.e006135.8","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S191418"},{"key":"2026050410252211000_11.4.e006135.9","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S2213-2600(19)30480-1","article-title":"Systemic sclerosis-associated interstitial lung disease","volume":"8","author":"Perelas","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026050410252211000_11.4.e006135.10","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(19)30144-4"},{"key":"2026050410252211000_11.4.e006135.11","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-024-03070-z","article-title":"Identification of progressive pulmonary fibrosis: consensus findings from a modified Delphi study","volume":"25","author":"Wells","year":"2024","journal-title":"Respir Res"},{"key":"2026050410252211000_11.4.e006135.12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0399ST"},{"key":"2026050410252211000_11.4.e006135.13","doi-asserted-by":"crossref","first-page":"103637","DOI":"10.1016\/j.autrev.2024.103637","article-title":"The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: A systematic review","volume":"23","author":"Campitiello","year":"2024","journal-title":"Autoimmun Rev"},{"key":"2026050410252211000_11.4.e006135.14","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13238"},{"key":"2026050410252211000_11.4.e006135.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-023-01044-x"},{"key":"2026050410252211000_11.4.e006135.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.06.008"},{"key":"2026050410252211000_11.4.e006135.17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031496","article-title":"Repolarization of Unbalanced Macrophages: Unmet Medical Need in Chronic Inflammation and Cancer","volume":"23","author":"Degbo\u00e9","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026050410252211000_11.4.e006135.18","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/8821610","article-title":"Regulatory Mechanism of M1\/M2 Macrophage Polarization in the Development of Autoimmune Diseases","volume":"2023","author":"Peng","year":"2023","journal-title":"Mediators Inflamm"},{"key":"2026050410252211000_11.4.e006135.19","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-025-01279-w"},{"key":"2026050410252211000_11.4.e006135.20","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1093\/rheumatology\/keac640","article-title":"Rheumatoid arthritis macrophages are primed for inflammation and display bioenergetic and functional alterations","volume":"62","author":"Hanlon","year":"2023","journal-title":"Rheumatology (Sunnyvale)"},{"key":"2026050410252211000_11.4.e006135.21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/rheumatology\/keac410","article-title":"Macrophages as determinants and regulators of fibrosis in systemic sclerosis","volume":"62","author":"Al-Adwi","year":"2023","journal-title":"Rheumatology (Sunnyvale)"},{"key":"2026050410252211000_11.4.e006135.22","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00790-8"},{"key":"2026050410252211000_11.4.e006135.23","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1237","article-title":"Rheumatoid arthritis CD14+ monocytes display metabolic and inflammatory dysfunction, a phenotype that precedes clinical manifestation of disease","volume":"10","author":"McGarry","year":"2021","journal-title":"Clin Transl Immunology"},{"key":"2026050410252211000_11.4.e006135.24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1352946","article-title":"Macrophage polarization: an important role in inflammatory diseases","volume":"15","author":"Luo","year":"2024","journal-title":"Front Immunol"},{"key":"2026050410252211000_11.4.e006135.25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.867260","article-title":"The Role of M1\/M2 Macrophage Polarization in Rheumatoid Arthritis Synovitis","volume":"13","author":"Cutolo","year":"2022","journal-title":"Front Immunol"},{"key":"2026050410252211000_11.4.e006135.26","doi-asserted-by":"publisher","DOI":"10.1038\/nri2448"},{"key":"2026050410252211000_11.4.e006135.27","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000835"},{"key":"2026050410252211000_11.4.e006135.28","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213648"},{"key":"2026050410252211000_11.4.e006135.29","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-018-0891-z","article-title":"A circulating cell population showing both M1 and M2 monocyte\/macrophage surface markers characterizes systemic sclerosis patients with lung involvement","volume":"19","author":"Trombetta","year":"2018","journal-title":"Respir Res"},{"key":"2026050410252211000_11.4.e006135.30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1488867","article-title":"Prevalence of hybrid TLR4+M2 monocytes\/macrophages in peripheral blood and lung of systemic sclerosis patients with interstitial lung disease","volume":"15","author":"Gotelli","year":"2024","journal-title":"Front Immunol"},{"key":"2026050410252211000_11.4.e006135.31","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204424"},{"key":"2026050410252211000_11.4.e006135.32","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000782","article-title":"Systemic sclerosis: state of the art on clinical practice guidelines","volume":"4","author":"Smith","year":"2018","journal-title":"RMD Open"},{"key":"2026050410252211000_11.4.e006135.33","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000660"},{"key":"2026050410252211000_11.4.e006135.34","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.semarthrit.2021.07.018","article-title":"Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort study","volume":"51","author":"Vandecasteele","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"2026050410252211000_11.4.e006135.35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903076"},{"key":"2026050410252211000_11.4.e006135.36","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"key":"2026050410252211000_11.4.e006135.37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/cyto.b.21228","article-title":"Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting","volume":"90","author":"Arroz","year":"2016","journal-title":"Cytometry B Clin Cytom"},{"key":"2026050410252211000_11.4.e006135.38","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202170126"},{"key":"2026050410252211000_11.4.e006135.39","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-024-03308-7","article-title":"Nintedanib downregulates the profibrotic M2 phenotype in cultured monocyte-derived macrophages obtained from systemic sclerosis patients affected by interstitial lung disease","volume":"26","author":"Soldano","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"2026050410252211000_11.4.e006135.40","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s13075-021-02691-9","article-title":"CTLA4-Ig treatment induces M1\u2013M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients","volume":"23","author":"Cutolo","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2026050410252211000_11.4.e006135.41","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262"},{"key":"2026050410252211000_11.4.e006135.42","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12206"},{"key":"2026050410252211000_11.4.e006135.43","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00058.2017"},{"key":"2026050410252211000_11.4.e006135.44","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e16206","article-title":"M2 macrophage polarization in systemic sclerosis fibrosis: pathogenic mechanisms and therapeutic effects","volume":"9","author":"Hu","year":"2023","journal-title":"Heliyon"},{"key":"2026050410252211000_11.4.e006135.45","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S50046"},{"key":"2026050410252211000_11.4.e006135.46","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00302.2023"},{"key":"2026050410252211000_11.4.e006135.47","doi-asserted-by":"crossref","first-page":"1243675","DOI":"10.3389\/fphar.2023.1243675","article-title":"Immunometabolism changes in fibrosis: from mechanisms to therapeutic strategies","volume":"14","author":"Feng","year":"2023","journal-title":"Front Pharmacol"},{"key":"2026050410252211000_11.4.e006135.48","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aax4067","article-title":"Hexokinase 2 couples glycolysis with the profibrotic actions of TGF-\u03b2","volume":"12","author":"Yin","year":"2019","journal-title":"Sci Signal"},{"key":"2026050410252211000_11.4.e006135.49","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02441-2018","article-title":"Proliferating SPP1\/MERTK-expressing macrophages in idiopathic pulmonary fibrosis","volume":"54","author":"Morse","year":"2019","journal-title":"Eur Respir J"},{"key":"2026050410252211000_11.4.e006135.50","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41420-024-02247-1","article-title":"Macrophages in organ fibrosis: from pathogenesis to therapeutic targets","volume":"10","author":"Jiang","year":"2024","journal-title":"Cell Death Discov"},{"key":"2026050410252211000_11.4.e006135.51","doi-asserted-by":"publisher","DOI":"10.1002\/art.22559"},{"key":"2026050410252211000_11.4.e006135.52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.559166"},{"key":"2026050410252211000_11.4.e006135.53","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/08820139.2025.2490898","article-title":"Macrophage Polarization in Lung Diseases: From Mechanisms to Therapeutic Strategies","volume":"54","author":"Wang","year":"2025","journal-title":"Immunol Invest"},{"key":"2026050410252211000_11.4.e006135.54","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1158\/0008-5472.CAN-21-3749","article-title":"IL6 and CCL18 Mediate Cross-talk between VHL-Deficient Kidney Cells and Macrophages during Development of Renal Cell Carcinoma","volume":"82","author":"Nguyen","year":"2022","journal-title":"Cancer Res"},{"key":"2026050410252211000_11.4.e006135.55","first-page":"3172","article-title":"Correction to: Association of serum interferon alpha-2a levels with disease severity and prognosis in systemic sclerosis","volume":"64","author":"Gerges","year":"2025","journal-title":"Rheumatology (Sunnyvale)"},{"key":"2026050410252211000_11.4.e006135.56","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1093\/rheumatology\/keaf134","article-title":"Identification of biomarkers and immune infiltration associated with sexes in SSc: a bioinformatics and machine learning","volume":"64","author":"Tian","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026050410252211000_11.4.e006135.57","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1298665","article-title":"Perspective to precision medicine in scleroderma","volume":"14","author":"Komura","year":"2023","journal-title":"Front Immunol"},{"key":"2026050410252211000_11.4.e006135.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2005.04.019"},{"key":"2026050410252211000_11.4.e006135.59","first-page":"331","article-title":"Macrophages, synovial tissue and rheumatoid arthritis","volume":"11","author":"Cutolo","year":"1993","journal-title":"Clin Exp Rheumatol"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2025-006135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T17:25:31Z","timestamp":1777915531000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2025-006135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":59,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12,11]]},"published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1136\/rmdopen-2025-006135"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2025-006135","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}